P3 Health Partners Inc (PIII)

$0.4799

-0.02

(-4.08%)▲

Market is closed - opens 7 PM, 26 Apr 2024

Insights on P3 Health Partners Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 288.35M → 346.86M (in $), with an average increase of 16.9% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -9.19M → -25.46M (in $), with an average decrease of 44.6% per quarter

  • Vs DVA

    In the last 1 year, Davita Healthcare Partners Inc. has given 53.9% return, outperforming this stock by 110.4%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 17.1% return, outperforming this stock by 112.0%

Performance

  • $0.46
    $0.50
    $0.48
    downward going graph

    4.17%

    Downside

    Day's Volatility :7.82%

    Upside

    3.81%

    downward going graph
  • $0.45
    $5.56
    $0.48
    downward going graph

    5.98%

    Downside

    52 Weeks Volatility :91.88%

    Upside

    91.37%

    downward going graph

Returns

PeriodP3 Health Partners IncSector (Health Care)Index (Russel 2000)
3 Months
-54.93%
1.1%
0.0%
6 Months
-65.73%
12.5%
0.0%
1 Year
-57.96%
6.9%
2.2%
3 Years
-94.88%
14.3%
-23.0%

Highlights

Market Capitalization
263.9M
Book Value
$1.22
Earnings Per Share (EPS)
-0.63
Wall Street Target Price
2.8
Profit Margin
-4.56%
Operating Margin TTM
-18.53%
Return On Assets TTM
-12.08%
Return On Equity TTM
-38.99%
Revenue TTM
1.3B
Revenue Per Share TTM
13.35
Quarterly Revenue Growth YOY
34.300000000000004%
Gross Profit TTM
-7.8M
EBITDA
-81.3M
Diluted Eps TTM
-0.63
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.28
EPS Estimate Next Year
-0.21
EPS Estimate Current Quarter
-0.11
EPS Estimate Next Quarter
-0.08

Analyst Recommendation

Buy
    81%Buy
    18%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for P3 Health Partners Inc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
8
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 483.45%

Current $0.48
Target $2.80

Company Financials

FY18Y/Y Change
Revenue
87.7M
-
Net Income
-43.8M
-
Net Profit Margin
-49.95%
-
FY19Y/Y Change
Revenue
145.5M
↑ 65.89%
Net Income
-42.0M
↓ 4.18%
Net Profit Margin
-28.85%
↑ 21.1%
FY20Y/Y Change
Revenue
485.5M
↑ 233.75%
Net Income
-31.4M
↓ 25.16%
Net Profit Margin
-6.47%
↑ 22.38%
FY22Y/Y Change
Revenue
491.1B
-
Net Income
-10.1M
-
Net Profit Margin
0.0%
-
FY23Y/Y Change
Revenue
1.3B
↓ 99.74%
Net Income
-57.8M
↑ 473.09%
Net Profit Margin
-4.56%
↓ 4.56%
Q3 FY22Q/Q Change
Revenue
490.6B
↑ 181973.63%
Net Income
76.1M
↓ 149.3%
Net Profit Margin
0.02%
↑ 57.3%
Q4 FY22Q/Q Change
Revenue
258.2M
↓ 99.95%
Net Income
-94.0M
↓ 223.58%
Net Profit Margin
-36.42%
↓ 36.44%
Q1 FY23Q/Q Change
Revenue
302.1M
↑ 16.99%
Net Income
-9.2M
↓ 90.22%
Net Profit Margin
-3.05%
↑ 33.37%
Q2 FY23Q/Q Change
Revenue
329.1M
↑ 8.94%
Net Income
-9.8M
↑ 6.71%
Net Profit Margin
-2.98%
↑ 0.07%
Q3 FY23Q/Q Change
Revenue
288.4M
↓ 12.38%
Net Income
-13.3M
↑ 35.45%
Net Profit Margin
-4.61%
↓ 1.63%
Q4 FY23Q/Q Change
Revenue
346.9M
↑ 20.29%
Net Income
-25.5M
↑ 91.5%
Net Profit Margin
-7.34%
↓ 2.73%
FY19Y/Y Change
Total Assets
65.6M
-
Total Liabilities
74.0M
-
FY20Y/Y Change
Total Assets
99.9M
↑ 52.28%
Total Liabilities
146.0M
↑ 97.29%
FY21Y/Y Change
Total Assets
2.4B
↑ 2266.42%
Total Liabilities
299.9M
↑ 105.5%
FY22Y/Y Change
Total Assets
2.4B
↑ 0.0%
Total Liabilities
299.9M
↑ 0.0%
FY23Y/Y Change
Total Assets
861.0M
↓ 63.58%
Total Liabilities
427.3M
↑ 42.46%
Q3 FY22Q/Q Change
Total Assets
1.4B
↑ 0.0%
Total Liabilities
328.5M
↑ 0.0%
Q4 FY22Q/Q Change
Total Assets
876.6M
↓ 39.3%
Total Liabilities
353.9M
↑ 7.73%
Q1 FY23Q/Q Change
Total Assets
867.4M
↓ 1.04%
Total Liabilities
396.4M
↑ 12.0%
Q2 FY23Q/Q Change
Total Assets
909.0M
↑ 4.79%
Total Liabilities
514.1M
↑ 29.69%
Q3 FY23Q/Q Change
Total Assets
896.9M
↓ 1.33%
Total Liabilities
395.9M
↓ 22.99%
Q4 FY23Q/Q Change
Total Assets
861.0M
↓ 4.01%
Total Liabilities
427.3M
↑ 7.94%
FY19Y/Y Change
Operating Cash Flow
-28.3M
↓ 3.25%
Investing Cash Flow
-3.9M
-
Financing Cash Flow
63.6M
↑ 91.34%
FY20Y/Y Change
Operating Cash Flow
-24.6M
↓ 13.05%
Investing Cash Flow
-3.2M
↓ 17.91%
Financing Cash Flow
34.8M
↓ 45.36%
FY21Y/Y Change
Operating Cash Flow
-66.5M
↑ 170.25%
Investing Cash Flow
-56.1M
↑ 1670.76%
Financing Cash Flow
223.5M
↑ 542.88%
Q3 FY22Q/Q Change
Operating Cash Flow
-24.6B
↑ 54092.41%
Investing Cash Flow
-1.1M
↑ 357.63%
Financing Cash Flow
34.7B
↓ 2804598.61%
Q4 FY22Q/Q Change
Operating Cash Flow
-32.0M
↓ 99.87%
Investing Cash Flow
-1.2M
↑ 3.36%
Financing Cash Flow
15.0M
↓ 99.96%
Q1 FY23Q/Q Change
Operating Cash Flow
-23.7M
↓ 25.76%
Investing Cash Flow
-464.0K
↓ 60.94%
Financing Cash Flow
14.1M
↓ 5.98%
Q2 FY23Q/Q Change
Operating Cash Flow
-28.8M
↑ 21.58%
Investing Cash Flow
-1.2M
↑ 156.03%
Financing Cash Flow
87.2M
↑ 518.04%

Technicals Summary

Sell

Neutral

Buy

P3 Health Partners Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
P3 Health Partners Inc
P3 Health Partners Inc
-50.95%
-65.73%
-57.96%
-94.88%
-94.83%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
9.73%
24.61%
-10.36%
-47.15%
-48.2%
Hca Holdings, Inc.
Hca Holdings, Inc.
-2.65%
43.83%
14.73%
59.06%
154.1%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
-3.97%
82.3%
37.12%
75.84%
305.2%
Universal Health Services Inc.
Universal Health Services Inc.
-6.72%
35.75%
17.89%
13.8%
25.97%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-1.86%
71.3%
53.87%
17.11%
138.7%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
P3 Health Partners Inc
P3 Health Partners Inc
NA
NA
NA
-0.28
-0.39
-0.12
NA
1.22
Fresenius Medical Care Ag
Fresenius Medical Care Ag
23.6
23.6
0.39
2.02
0.05
0.03
0.03
46.42
Hca Holdings, Inc.
Hca Holdings, Inc.
16.84
16.84
1.44
20.64
0.12
0.11
0.01
-6.68
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
17.21
17.21
2.2
6.03
0.26
0.06
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
16.14
16.14
1.87
13.45
0.12
0.05
0.0
91.53
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
18.05
18.05
1.16
9.01
0.39
0.06
NA
11.89
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
P3 Health Partners Inc
P3 Health Partners Inc
Buy
$263.9M
-94.83%
NA
-4.56%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$12.6B
-48.2%
23.6
2.57%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$84.5B
154.1%
16.84
8.07%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$9.7B
305.2%
17.21
2.97%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$11.1B
25.97%
16.14
5.03%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$11.7B
138.7%
18.05
5.7%

Institutional Holdings

  • Ameriprise Financial Inc

    4.72%

  • HHG PLC

    3.28%

  • BlackRock Inc

    2.21%

  • Alyeska Investment Group, L.P.

    1.70%

  • Vanguard Group Inc

    1.35%

  • EMFO, LLC

    0.87%

Corporate Announcements

  • P3 Health Partners Inc Earnings

    P3 Health Partners Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

p3 health partners (p3) is a patient-centered, physician-led and population health-focused healthcare company. founded and led by physicians, sherif abdou, and amir bacchus, p3 is a team of doctors, clinicians and support service professionals with a shared passion and purpose for improving the way patient care is delivered. we are on a mission to change the way healthcare is delivered. we believe that together as physicians, we can heal the system, restore purpose and meaning in day-to-day operations, and infuse care and health back into healthcare.

Organization
P3 Health Partners Inc
Employees
400
CEO
Dr. Sherif Abdou F.A.C.E.P., FACP, M.D.
Industry
Services

Discover More

FAQs